Loading clinical trials...
Loading clinical trials...
Clinical phase I, controlled, non comparative, open, single center study evaluating the safety and tolerability of ophthalmic solution PRO-172 when applied on the ocular surface of healthy volunteers.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Laboratorios Sophia S.A de C.V.
NCT07605572 · Dry Eye Disease (DED), Diabete Mellitus, and more
NCT07367906 · Medical Education, Patient Safety
NCT05937750 · Long Term Efficacy and Safety
NCT07256522 · Trigger Finger, Splint Therapy, and more
NCT04354545 · Glaucoma, Ocular Surface Disease
Unidad Clínica de Bioequivalencia, S. de R.L. de C.V.
Guadalajara, Jalisco
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions